Upon silencing of TAp73 in a cell line derived from these mice, both Bgn and Smad3 were downregulated, suggesting the exciting possibility that Rac1b is targeted by TAp73 to participate in its tumor-suppressive function in pancreatic cancer. Here, SMAD3 is linked to pancreatic neoplasm.